(5R,6S,7S)-5,6-dihydroxy-8-(alpha-D-galactosyloxy)-7-octanamido-N-(8-phenyloctyl)octanamide

Term ID

CHEBI:139112

Synonyms

(5R,6S,7S)-5,6-dihydroxy-7-(octanoylamino)-N-(8-phenyloctyl)-8-{[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl]oxy}octanamide
(5R,6S,7S)-5,6-dihydroxy-8-(alpha-D-galactopyranosyloxy)-7-(octanoylamino)-N-(6-phenyloctyl)octanamide
(5R,6S,7S)-5,6-dihydroxy-8-O-(alpha-D-galactopyranosyl)-7-octanamido-N-(8-phenyloctyl)octanamide
N-((2S,3S,4R)-1-O-(alpha-D-galactopyranosyl)-3,4-dihydroxy-16-phenylhexadecan-2-yl)octanamide

Definition

A synthetic alpha-galactosylsphingamide in which the galactose ring carries a (2S,3S,4R)-3,4-dihydroxy-2-(octanoylamino)-8-oxo-8-[(8-phenyloctyl)amino]octyl moiety at O-1.

References

PMID:28655912
Patent:WO201783830
Reaxys:31280482

Ontology

ChEBI ( EBI )

Relationships

is a type of: alpha-galactosylsphingamide

alpha-galactosylsphingamide Show first 5 Terms

Phenotype

Phenotype resulting from (5R,6S,7S)-5,6-dihydroxy-8-(alpha-D-galactosyloxy)-7-octanamido-N-(8-phenyloctyl)octanamide

Phenotype where environments contain (5R,6S,7S)-5,6-dihydroxy-8-(alpha-D-galactosyloxy)-7-octanamido-N-(8-phenyloctyl)octanamide

Phenotype modified by environments containing (5R,6S,7S)-5,6-dihydroxy-8-(alpha-D-galactosyloxy)-7-octanamido-N-(8-phenyloctyl)octanamide

Human Disease Model